Susan Stewart, director of Blood and Marrow Transplant InfoN

UNITED STATES - MAY 09: Susan Stewart, director of Blood and Marrow Transplant InfoNet, speaks to an expert panel regarding approval of the drug OrBec during a Food and Drug Administration Advisory Committee meeting in Silver Spring, Maryland May 9, 2007. DOR Biopharma Inc. urged U.S. regulators to approve its drug for graft versus host disease, a lethal complication that leukemia patients get after bone marrow transplants. (Photo by Ken Cedeno/Bloomberg via Getty Images)
UNITED STATES - MAY 09: Susan Stewart, director of Blood and Marrow Transplant InfoNet, speaks to an expert panel regarding approval of the drug OrBec during a Food and Drug Administration Advisory Committee meeting in Silver Spring, Maryland May 9, 2007. DOR Biopharma Inc. urged U.S. regulators to approve its drug for graft versus host disease, a lethal complication that leukemia patients get after bone marrow transplants. (Photo by Ken Cedeno/Bloomberg via Getty Images)
Susan Stewart, director of Blood and Marrow Transplant InfoN
PURCHASE A LICENSE
How can I use this image?
kr. 3.000,00
DKK

DETAILS

Restrictions:
Contact your local office for all commercial or promotional uses.For editorial use only. Additional clearance required for commercial or promotional use, contact your local office for assistance. Any commercial or promotional use of Bloomberg content requires Bloomberg’s prior written consent.
Credit:
Bloomberg / Contributor
Editorial #:
94603584
Collection:
Bloomberg
Date created:
May 09, 2007
Upload date:
License type:
Rights-managed
Release info:
Not released. More information
Source:
Bloomberg
Object name:
pdir0823\PHi_j0186.JPG
Max file size:
1600 x 2400 px (5.33 x 8.00 in) - 300 dpi - 1 MB